In this InvestorIntel interview, Tracy Weslosky talks with Zentek Ltd.‘s (NASDAQ: ZTEK | TSXV: ZEN) CEO and Director Greg Fenton about an update on the commercialization of Zentek’s patented ZenGUARD™ antimicrobial technology.
With the ability to increase viral filtration efficiency of an HVAC (Heating, Ventilation, and Air Conditioning) filter by almost 5 times, Greg explains how a ZenGUARD™ coated HVAC filter is an incredibly safe way to improve indoor air quality and remove pathogens from the air without any additional energy requirements.
Although currently going through a regulatory approval process through Health Canada’s Pest Management Regulatory Agency (“PMRA”) in Canada, ZenGUARD™ has already received approval from another branch of Health Canada, indicating a high likelihood of approval from PMRA. Greg also discusses how ZenGUARD™ is seeing a growing demand from end users including filter manufacturers, provincial and municipal governments, and private sector customers.
To access the full InvestorIntel interview, click here
Don’t miss other InvestorIntel interviews. Subscribe to the InvestorIntel YouTube channel by clicking here.
About Zentek Ltd.
Zentek is a graphene technology company focused on the research, development, and commercialization of graphene-based novel products to give its commercial partners a competitive advantage by making their products better, safer, and greener.
Zentek’s patented ZenGUARD™ coating is shown to have 99-per-cent anti-microbial activity and to significantly increase the bacterial and viral filtration efficiency of both surgical masks and HVAC systems. Zentek’s ZenGUARD™ production facility is located in Guelph, Ont. Zentek’s second technology is the patent-pending ZenARMOR™ platform focused on corrosion protection applications.
To know more about Zentek Ltd., click here
Disclaimer: Zentek Ltd. is an advertorial member of InvestorIntel Corp.
This interview, which was produced by InvestorIntel Corp., (IIC), does not contain, nor does it purport to contain, a summary of all the material information concerning the “Company” being interviewed. IIC offers no representations or warranties that any of the information contained in this interview is accurate or complete.
This presentation may contain “forward-looking statements” within the meaning of applicable Canadian securities legislation. Forward-looking statements are based on the opinions and assumptions of the management of the Company as of the date made. They are inherently susceptible to uncertainty and other factors that could cause actual events/results to differ materially from these forward-looking statements. Additional risks and uncertainties, including those that the Company does not know about now or that it currently deems immaterial, may also adversely affect the Company’s business or any investment therein.
Any projections given are principally intended for use as objectives and are not intended, and should not be taken, as assurances that the projected results will be obtained by the Company. The assumptions used may not prove to be accurate and a potential decline in the Company’s financial condition or results of operations may negatively impact the value of its securities. Prospective investors are urged to review the Company’s profile on Sedar.com and to carry out independent investigations in order to determine their interest in investing in the Company.
If you have any questions surrounding the content of this interview, please contact us at +1 416 792 8228 and/or email us direct at [email protected].
Leave a Reply